The Developmental Core has been a crucial component of the Emory CFAR through its efforts to attract and mentor junior scientists in HIV research. Under the direction of Drs. Dennis Liotta and Kimberly Hagen, the primary goals of Core B (Developmental) are to: 1) Assist in the recruitment and retention of high-priority HIV/AIDS investigators to the Emory CFAR; 2) Increase the capacity of junior, foreign, and new investigators to develop competitive applications for extramural HIV/AIDS funding by providing mentoring in grantsmanship and research; 3) Increase the capacity of junior and new investigators to successfully apply for extramural HIV/AIDS funding by providing peer-reviewed seed grants for the development of preliminary data through the CFAR03 program (modeled after the NIHR03 program); 4) Reduce obstacles to new and ongoing HIV research, facilitate HIV/AIDS research career development, and enhance science communication by providing fill-in funding through a Micro Grant program; 5) Increase the capacity of local Historically Black Colleges and Universities (HCBUs) to do HIV/AIDS research by promoting collaborative research opportunities with CFAR investigators and encouraging HCBU faculty to apply independently for CFAR03 and Micro Grant awards; 6) Strengthen the capacity for HIV/AIDS research in developing countries by targeting developmental awards to AITRP collaborators (I-CFAR03 funding), co-sponsoring a visiting researcher program, and providing technical assistance to foreign field sites; Small grant grant proposals will be reviewed by the CFAR Scientific Review Group (SRG). The SRG constitutes an interdisciplinary peer-review body that will evaluate the scientific merit of proposals and make funding recommendations. Special priority will be given to proposals involving interdisciplinary collaborations, feasibility studies, or pilot studies examining emerging questions in HIV/AIDS. Within categories, priority consideration will be given to applications from minority investigators.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
United States
Zip Code
Singleton, Robyn; Winskell, Kate; Nkambule-Vilakati, Siphiwe et al. (2018) Young Africans' social representations of rape in their HIV-related creative narratives, 2005-2014: Rape myths and alternative narratives. Soc Sci Med 198:112-120
Palesch, David; Bosinger, Steven E; Tharp, Gregory K et al. (2018) Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host. Nature 553:77-81
Sullivan, Patrick S (2018) Practical Considerations for Implementing a New Syphilis Action Plan. Sex Transm Dis 45:S78-S79
Sullivan, Patrick S; Giler, Robertino Mera; Mouhanna, Farah et al. (2018) Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Ann Epidemiol 28:833-840
Dillard, Rebecca S; Hampton, Cheri M; Strauss, Joshua D et al. (2018) Biological Applications at the Cutting Edge of Cryo-Electron Microscopy. Microsc Microanal 24:406-419
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Ke, Zunlong; Dillard, Rebecca S; Chirkova, Tatiana et al. (2018) The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography. Viruses 10:
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114
Adimora, Adaora A; Ramirez, Catalina; Benning, Lorie et al. (2018) Cohort Profile: The Women's Interagency HIV Study (WIHS). Int J Epidemiol 47:393-394i
Auld, Sara C; Shah, N Sarita; Mathema, Barun et al. (2018) Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities. Eur Respir J 52:

Showing the most recent 10 out of 1005 publications